Phio Pharmaceuticals Corp is a biotechnology business based in the US. Phio Pharmaceuticals shares (PHIO) are listed on the NASDAQ and all prices are listed in US Dollars. Phio Pharmaceuticals employs 10 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Phio Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PHIO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Phio Pharmaceuticals stock price (NASDAQ: PHIO)Use our graph to track the performance of PHIO stocks over time.
Phio Pharmaceuticals shares at a glance
|Latest market close||$2.22|
|52-week range||$1.72 - $4.36|
|50-day moving average||$2.10|
|200-day moving average||$2.57|
|Wall St. target price||$6.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.45|
Buy Phio Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Phio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Phio Pharmaceuticals price performance over time
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||2.78%|
|3 months (2021-05-04)||2.22|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
Phio Pharmaceuticals financials
|Gross profit TTM||$-4,431,000|
|Return on assets TTM||-26.15%|
|Return on equity TTM||-45.41%|
|Market capitalisation||$24.8 million|
TTM: trailing 12 months
Shorting Phio Pharmaceuticals shares
There are currently 1.1 million Phio Pharmaceuticals shares held short by investors – that's known as Phio Pharmaceuticals's "short interest". This figure is 8.6% up from 1.1 million last month.
There are a few different ways that this level of interest in shorting Phio Pharmaceuticals shares can be evaluated.
Phio Pharmaceuticals's "short interest ratio" (SIR)
Phio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Phio Pharmaceuticals shares currently shorted divided by the average quantity of Phio Pharmaceuticals shares traded daily (recently around 318729.05027933). Phio Pharmaceuticals's SIR currently stands at 3.58. In other words for every 100,000 Phio Pharmaceuticals shares traded daily on the market, roughly 3580 shares are currently held short.
However Phio Pharmaceuticals's short interest can also be evaluated against the total number of Phio Pharmaceuticals shares, or, against the total number of tradable Phio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phio Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Phio Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.0846% of the tradable shares (for every 100,000 tradable Phio Pharmaceuticals shares, roughly 85 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Phio Pharmaceuticals.
Find out more about how you can short Phio Pharmaceuticals stock.
Phio Pharmaceuticals share dividends
We're not expecting Phio Pharmaceuticals to pay a dividend over the next 12 months.
Have Phio Pharmaceuticals's shares ever split?
Phio Pharmaceuticals's shares were split on a 1:55 basis on 14 January 2020. So if you had owned 55 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Phio Pharmaceuticals shares – just the quantity. However, indirectly, the new 5400% higher share price could have impacted the market appetite for Phio Pharmaceuticals shares which in turn could have impacted Phio Pharmaceuticals's share price.
Phio Pharmaceuticals share price volatility
Over the last 12 months, Phio Pharmaceuticals's shares have ranged in value from as little as $1.72 up to $4.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phio Pharmaceuticals's is 2.2116. This would suggest that Phio Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Phio Pharmaceuticals overview
Phio Pharmaceuticals Corp. , a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762, which targets the checkpoint protein PD-1 that prevent T cells from attacking various cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that prevent cancer cells from inactivating T cells and attack the cancer. It has collaboration with AgonOx, Inc. on clinical development of novel immunotherapy drugs targeting key regulators of the immune response to cancer. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp.
Stocks similar to Phio Pharmaceuticals
Phio Pharmaceuticals in the news
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Stocks That Hit 52-Week Lows On Monday
Phio Pharmaceuticals participates in a conference call with H.C. Wainwright
Frequently asked questionsWhat percentage of Phio Pharmaceuticals is owned by insiders or institutions?
Currently 0.288% of Phio Pharmaceuticals shares are held by insiders and 7.93% by institutions. How many people work for Phio Pharmaceuticals?
Latest data suggests 10 work at Phio Pharmaceuticals. When does the fiscal year end for Phio Pharmaceuticals?
Phio Pharmaceuticals's fiscal year ends in December. Where is Phio Pharmaceuticals based?
Phio Pharmaceuticals's address is: 257 Simarano Drive, Marlborough, MA, United States, 01752 What is Phio Pharmaceuticals's ISIN number?
Phio Pharmaceuticals's international securities identification number is: US71880W3034 What is Phio Pharmaceuticals's CUSIP number?
Phio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 71880W204
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert